Kaplan-Meier survival analysis revealed that the expression levels of ANLN, BMP2, CALU, COL1A1, COL1A2, COL3A1, ERO1A, FSCN1, FZD3, LOXL2, MME, MSI2, NFIX, PTX3, RTKN2, SLC2A1, SLC16A1, and SNX30 were relevant with poor prognosis in NSCLC patients (Figure 7). Here, SLC2A1 is linked to non-small cell lung carcinoma.